Xcellerex Initiates Phase I Clinical Trial of Yellow Fever Vaccine

News   Jan 13, 2010

 
Xcellerex Initiates Phase I Clinical Trial of Yellow Fever Vaccine
 
 
 

RELATED ARTICLES

Synaptic Proteins May Be Starting Point for Dementia Treatment

News

A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.

READ MORE

Brian Berridge Set to Manage National Toxicology Program

News

The National Toxicology Program (NTP) has named Brian Berridge, D.V.M., Ph.D., as its new Associate Director. Berridge, formerly of GlaxoSmithKline, will oversee day-to-day operations as NTP coordinates toxicology research and testing across nine different federal agencies.

READ MORE

Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

News

An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE